Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-19175
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Eichler, Klaus | - |
dc.contributor.author | Rapold, Ronald | - |
dc.contributor.author | Wieser, Simon | - |
dc.contributor.author | Reich, Oliver | - |
dc.contributor.author | Blozik, Eva | - |
dc.date.accessioned | 2020-01-23T15:14:44Z | - |
dc.date.available | 2020-01-23T15:14:44Z | - |
dc.date.issued | 2019-10 | - |
dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/19175 | - |
dc.format.extent | 37 | de_CH |
dc.language.iso | en | de_CH |
dc.publisher | ZHAW Zürcher Hochschule für Angewandte Wissenschaften | de_CH |
dc.rights | http://creativecommons.org/licenses/by/4.0/ | de_CH |
dc.subject | Multiple myeloma | de_CH |
dc.subject | Drug treatment | de_CH |
dc.subject | Treatment patterns | de_CH |
dc.subject | Costs | de_CH |
dc.subject.ddc | 362.1041: Gesundheitsökonomie | de_CH |
dc.subject.ddc | 615: Pharmakologie und Therapeutik | de_CH |
dc.title | Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description | de_CH |
dc.type | Working Paper – Gutachten – Studie | de_CH |
dcterms.type | Text | de_CH |
zhaw.departement | School of Management and Law | de_CH |
zhaw.organisationalunit | Winterthurer Institut für Gesundheitsökonomie (WIG) | de_CH |
zhaw.publisher.place | Winterthur | de_CH |
dc.identifier.doi | 10.21256/zhaw-19175 | - |
zhaw.funding.eu | No | de_CH |
zhaw.originated.zhaw | Yes | de_CH |
zhaw.author.additional | No | de_CH |
Appears in collections: | Gesundheitsökonomie |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Multiple Myeloma Drug Regimes_2019.pdf | 527.94 kB | Adobe PDF | View/Open |
Show simple item record
Eichler, K., Rapold, R., Wieser, S., Reich, O., & Blozik, E. (2019). Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-19175
Eichler, K. et al. (2019) Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. Available at: https://doi.org/10.21256/zhaw-19175.
K. Eichler, R. Rapold, S. Wieser, O. Reich, and E. Blozik, “Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description,” ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Winterthur, Oct. 2019. doi: 10.21256/zhaw-19175.
EICHLER, Klaus, Ronald RAPOLD, Simon WIESER, Oliver REICH und Eva BLOZIK, 2019. Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description. Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Eichler, Klaus, Ronald Rapold, Simon Wieser, Oliver Reich, and Eva Blozik. 2019. “Real-World Drug Regimes for Multiple Myeloma in a Swiss Population (2012 to 2017) : Cost-Outcome Description.” Winterthur: ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-19175.
Eichler, Klaus, et al. Real-World Drug Regimes for Multiple Myeloma in a Swiss Population (2012 to 2017) : Cost-Outcome Description. ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Oct. 2019, https://doi.org/10.21256/zhaw-19175.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.